Godelaine et al. investigated the prognostic value of serum neurofilament light chain in chronic inflammatory demyelinating polyneuropathy and showed in various logistic regression models that elevated serum neurofilament light chain levels were significantly associated with increased odds of 1-year disease progression, not responding to therapy during follow-up or both. The gene discussed is NEFL; the disease is chronic inflammatory demyelinating polyradiculoneuropathy.